These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37088153)

  • 41. [Preparation and in vitro embolic efficiency evaluation of hydroxycamptothecine-loaded liquid embolic agent].
    Qin LZ; Zhang X; Wu LN; Zhang J; Pan X; Li G; Wu CB
    Yao Xue Xue Bao; 2014 Jul; 49(7):1069-75. PubMed ID: 25233642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An environmentally safe larvicide against Aedes aegypti based on in situ gelling nanostructured surfactant systems containing an essential oil.
    Ferreira SG; Conceição VS; Gouveia NS; Santos GS; Santos RL; Lira AA; Cavalcanti SC; Sarmento VH; Nunes RS
    J Colloid Interface Sci; 2015 Oct; 456():190-6. PubMed ID: 26125515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and Evaluation of Minocycline Hydrochloride-Loaded In Situ Cubic Liquid Crystal for Intra-Periodontal Pocket Administration.
    Yang Z; Liang X; Jiang X; Guo J; Tao Y; Wang S; Cao Y; Gui S
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30200615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of magnesium aluminium silicate on rheological, release and permeation characteristics of diclofenac sodium aqueous gels in-vitro.
    Pongjanyakul T; Priprem A; Puttipipatkhachorn S
    J Pharm Pharmacol; 2005 Apr; 57(4):429-34. PubMed ID: 15831202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lyotropic liquid crystals for parenteral drug delivery.
    Chavda VP; Dawre S; Pandya A; Vora LK; Modh DH; Shah V; Dave DJ; Patravale V
    J Control Release; 2022 Sep; 349():533-549. PubMed ID: 35792188
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lyotropic Liquid-Crystalline Nanosystems as Drug Delivery Agents for 5-Fluorouracil: Structure and Cytotoxicity.
    Astolfi P; Giorgini E; Gambini V; Rossi B; Vaccari L; Vita F; Francescangeli O; Marchini C; Pisani M
    Langmuir; 2017 Oct; 33(43):12369-12378. PubMed ID: 29023126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In situ gelling hexagonal phases for sustained release of an anti-addiction drug.
    Phelps J; Bentley MV; Lopes LB
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):391-8. PubMed ID: 21703826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A study of microemulsions as prolonged-release injectables through in-situ phase transition.
    Wu Z; Alany RG; Tawfeek N; Falconer J; Zhang W; Hassan IM; Rutland M; Svirskis D
    J Control Release; 2014 Jan; 174():188-94. PubMed ID: 24316265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Investigation of diclofenac release and dynamic structural behavior of non-lamellar liquid crystal formulations during in situ formation by UV-Vis imaging and SAXS.
    Mertz N; Bock F; Østergaard J; Yaghmur A; Weng Larsen S
    Int J Pharm; 2022 Jul; 623():121880. PubMed ID: 35661744
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz.
    Avachat AM; Parpani SS
    Colloids Surf B Biointerfaces; 2015 Feb; 126():87-97. PubMed ID: 25543986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Solvation Dynamics in Different Phases of the Lyotropic Liquid Crystalline System.
    Roy B; Satpathi S; Gavvala K; Koninti RK; Hazra P
    J Phys Chem B; 2015 Sep; 119(35):11721-31. PubMed ID: 26258397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure-rheology relationship in monoolein liquid crystals.
    Mistry S; Fuhrmann PL; de Vries A; Karshafian R; Rousseau D
    J Colloid Interface Sci; 2023 Jan; 630(Pt B):878-887. PubMed ID: 36356453
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase transition and release kinetics of polyphenols encapsulated lyotropic liquid crystals.
    Zhang H; Wang Z
    Int J Pharm; 2019 Jun; 565():283-293. PubMed ID: 31078646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An injectable liquid crystal system for sustained delivery of entecavir.
    Lim JL; Ki MH; Joo MK; An SW; Hwang KM; Park ES
    Int J Pharm; 2015 Jul; 490(1-2):265-72. PubMed ID: 26004002
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In situ monitoring of the formation of lipidic non-lamellar liquid crystalline depot formulations in synovial fluid.
    Yaghmur A; Rappolt M; Jonassen ALU; Schmitt M; Larsen SW
    J Colloid Interface Sci; 2021 Jan; 582(Pt B):773-781. PubMed ID: 32916575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new injectable liquid crystal system for one month delivery of leuprolide.
    Ki MH; Lim JL; Ko JY; Park SH; Kim JE; Cho HJ; Park ES; Kim DD
    J Control Release; 2014 Jul; 185():62-70. PubMed ID: 24794897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. H
    Liang X; Chen YL; Jiang XJ; Wang SM; Zhang JW; Gui SY
    Eur J Pharm Sci; 2017 Mar; 100():155-162. PubMed ID: 28063969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In situ hexagonal liquid crystal for intra-articular delivery of sinomenine hydrochloride.
    Liang X; Chen Y; Wu L; Maharjan A; Regmi B; Zhang J; Gui S
    Biomed Pharmacother; 2019 Sep; 117():108993. PubMed ID: 31228805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization and In Vitro Permeation Study of Cubic Liquid Crystal Containing Sinomenine Hydrochloride.
    Chu X; Li Q; Gui S; Li Z; Cao J; Jiang J
    AAPS PharmSciTech; 2018 Jul; 19(5):2237-2246. PubMed ID: 29740759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of Lipid-Based Lyotropic Liquid Crystal and Effects of Guest Molecules on Its Microstructure: a Systematic Review.
    Wang X; Zhang Y; Gui S; Huang J; Cao J; Li Z; Li Q; Chu X
    AAPS PharmSciTech; 2018 Jul; 19(5):2023-2040. PubMed ID: 29869308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.